WHO to bolster fight against counterfeit medicine

BUENOS AIRES, Nov. 21 (Xinhua) -- Members of the World Health Organization (WHO) agreed Wednesday in Buenos Aires to strengthen regulations to fight counterfeit medicines, the organization said.

Representatives from 76 WHO members also pledged to outline actions and policies to control and prevent the adulteration of products and guarantee safer, better quality medications at a meeting aiming to establish a mechanism against substandard and counterfeit medical products, it said in a statement.

To that end, 200 participants to the meeting, including WHO General Director Margaret Chen, agreed on a work plan that establishes the need for cooperation among governments to share best practices and experiences against counterfeit medical products.

During the meeting, the participants also agreed to form a WTO global committee to monitor the plan's implementation.

"The committee includes the improvement of national regulatory agencies to strengthen their capacity and quality control of laboratories through policies and legal instruments," the WHO said.

Recommended Features: Vibrant Opportunities amid Transition From 'Made in China' to 'Created in China' A Journey to Cultural Renaissance The Vision of A Pillar Industry China: A Fast- growing Force in IPR IPR in China: Local Roots Bearing Global Fruits A Decade of Fastest Development Eastern Boom Lightens Western Gloom Chinese firms 'potential Trojan horses'？